von Tobias Borgers | Jan. 19, 2024 | Boehringer
INGELHEIM, Germany and SOUTH SAN FRANCISCO, Calif., Jan. 4, 2024 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. and 3T Biosciences („3T“) today announced they have entered into a new strategic collaboration and licensing agreement focused...
von Tobias Borgers | Jan. 19, 2024 | Bayer
Sun Pharmaceutical Industries Limited and Bayer on Thursday announced that both companies have signed an agreement to market and distribute a second brand of Finerenone in India. According to the company’s press statement, Finerenone, a patented medicine is indicated...
von Tobias Borgers | Jan. 10, 2024 | Boehringer
INGELHEIM, Germany and SOUTH SAN FRANCISCO, Calif., Jan. 4, 2024 /PRNewswire/ — Boehringer Ingelheim and 3T Biosciences („3T“) today announced they have entered into a new strategic collaboration and licensing agreement focused on discovering and...
von Tobias Borgers | Jan. 10, 2024 | Glaxo
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway AIO-001 could redefine the standard-of-care with dosing every six months AIO-001 has potential to expand GSK’s...
von Tobias Borgers | Dez. 21, 2023 | Boehringer
This webcast features: Athelney Woolnough, Director Business Development/Key Account Management BioXcellence, Franz Schuster, Strategy Implementation Manager Biopharma Austria, Cécile Brocard, Director of Downstream Development, Process Science RCV, Boehringer...
von Tobias Borgers | Dez. 21, 2023 | Boehringer
RealmFive, a leader in data connectivity and digital solutions based in Lincoln, Neb., has teamed up with Boehringer Ingelheim Animal Health, to commercialize next-generation technology-based solutions for advancing remote connectivity and herd health across the swine...
